Financial Review: Inspira Technologies OXY B.H.N. (NASDAQ:IINN) versus AxoGen (NASDAQ:AXGN)

AxoGen (NASDAQ:AXGN) and Inspira Technologies OXY B.H.N. (NASDAQ:IINN) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings and valuation.

Profitability

This table compares AxoGen and Inspira Technologies OXY B.H.N.’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
AxoGen	-0.98%	-1.90%	-1.02%
Inspira Technologies OXY B.H.N.	N/A	N/A	N/A

Analyst Recommendations

This is a summary of recent ratings and target prices for AxoGen and Inspira Technologies OXY B.H.N., as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AxoGen	1	0	9	0	2.80
Inspira Technologies OXY B.H.N.	1	0	1	0	2.00

AxoGen presently has a consensus target price of $35.56, suggesting a potential upside of 8.27%. Inspira Technologies OXY B.H.N. has a consensus target price of $2.00, suggesting a potential upside of 108.33%. Given Inspira Technologies OXY B.H.N.’s higher probable upside, analysts plainly believe Inspira Technologies OXY B.H.N. is more favorable than AxoGen.

Institutional and Insider Ownership

80.3% of AxoGen shares are owned by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. 2.8% of AxoGen shares are owned by company insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Volatility and Risk

AxoGen has a beta of 1.06, suggesting that its share price is 6% more volatile than the S&P 500. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 2.25, suggesting that its share price is 125% more volatile than the S&P 500.

Earnings and Valuation

This table compares AxoGen and Inspira Technologies OXY B.H.N.”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AxoGen	$187.34 million	8.08	-$9.96 million	($0.05)	-656.80
Inspira Technologies OXY B.H.N.	N/A	N/A	-$11.05 million	N/A	N/A

AxoGen has higher revenue and earnings than Inspira Technologies OXY B.H.N..

Summary

Inspira Technologies OXY B.H.N. beats AxoGen on 6 of the 11 factors compared between the two stocks.

About AxoGen

AxoGen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company’s products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. AxoGen, Inc. is headquartered in Alachua, Florida.

About Inspira Technologies OXY B.H.N.

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'annana, Israel.